The purpose of this review is to provide a retrospective summary of NRF2-associated epigenetic modifications in DM-related cardiac and vascular complications and discuss NRF2 agonists that could potentially be used to regulate NRF2-associated epigenetic mechanisms. The gene discussed is NFE2L2; the disease is diabetes mellitus.